ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.Catherine M. Albert, Julie R. Park, Stephanie Rawlings-Rhea et al.|Journal of Clinical Oncology|2023Cited by 6
Abstract CT137: ENLIGHTen-01: a phase 1 study of fluorescein-specific (FITC-E2)-car T cells in combination with folate-fluorescein (UB-TT170) for osteosarcomaCatherine M. Albert, Julie R. Park, Navin Pinto et al.|Cancer Research|2023Cited by 1